InMed Pharmaceuticals Alternatives & Competitors
12 companies similar to InMed Pharmaceuticals — Global leader in the manufacturing and development of rare cannabinoids. Our sub...
Companies similar to InMed Pharmaceuticals
BayMedica
BayMedica leverages synthetic biology and chemistry to develop rare cannabinoids. A divisi...
United States
TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals is a clinical stage pharmaceutical company committed to extending a he...
Baltimore, United States
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Bresso, Italy
Remix Therapeutics
Reprogramming RNA Processing, Designing Therapeutic Solutions
United States
Rival Readout
Competing with InMed Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Acer Therapeutics Inc.
Focused on the acquisition, development & commercialization of therapies for serious rare...
Newton, United States
Altay Therapeutics
Unlocking Transcription Factors to Address Unmet Medical Need
San Francisco, United Sta...
Azevan Pharmaceuticals
Innovative therapies for stress, mood, and behavior disorders
BeBetter Med
Clinical-stage drug discovery and development of advanced novel medicines for cancer and o...
China
Forward Pharma
Pioneering new therapies in oncology and autoimmunity through advanced small-molecule phar...
About InMed Pharmaceuticals
InMed Pharmaceuticals, founded in 1981, is a biotechnology company headquartered in Canada. The company is recognized as a global leader in the manufacturing and development of rare cannabinoids, strategically aligning with its subsidiary, BayMedica. With a focus on developing proprietary small molecule drug candidates...
Pharmaceuticals, Drug Development, Cannabinoids, Rare Cannabinoids, Therapeutic Medications, Alzheimer's Treatment, Ocular Indications, Dermatological Indications, Small Molecule Drugs, Clinical-stage Pharmaceuticals, CB1/CB2 Receptors, Medical Research
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around InMed Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at InMed Pharmaceuticals on 15 Nov 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
